TP53 and cancer: Analysis of iASPP mutations in a wide range of cancers did not reveal particular hotspot mutations and, unlike the mutations associated with cardiomyopathy, most of the mutants selected for further characterisation neither aggregated nor reside at the hydrophobic core or binding interface between iASPP and p53.